To evaluate the effects of two different antihypertensive medications in the drug class of beta-blockers on control of glucose in Type II diabetic patients with high blood pressure.

Inclusion criteria:

• Patients at screening must be insulin producing Type II diabetics (C peptide positive).
• Must have a history of mild to moderate hypertension (140-179 systolic; 90-1-9 diastolic).
• Must be on stable regimen of ACE (angiotensin converting enzyme) / ARB (angiotensin receptor blocker) treatment alone or in combination with other treatments.
• Patient''s laboratory result for HbA1c must be 6.5 - 8.5 (drug treated) or 6.5 - 7.5 (diet alone).
• Must be on a stable antidiabetic regimen (drug treated or diet alone).

Exclusion criteria:

• Patients using beta-blocker therapy.